Daniel Abdun-Nabi's Net Worth
$23.4 Million
Who is Daniel Abdun-Nabi?
Daniel Abdun-Nabi has an estimated net worth of $23.4 Million. This is based on reported shares across multiple companies, which include REGENXBIO Inc., Emergent BioSolutions Inc., and Aptevo Therapeutics Inc..
SEC CIK
Daniel Abdun-Nabi's CIK is 0001380187
Past Insider Trading and Trends
2007 was Daniel Abdun-Nabi's most active year for acquiring shares with 26 total transactions. Daniel Abdun-Nabi's most active month to acquire stocks was the month of May. 2007 was Daniel Abdun-Nabi's most active year for disposing of shares, totalling 48 transactions. Daniel Abdun-Nabi's most active month to dispose stocks was the month of May. 2018 saw Daniel Abdun-Nabi paying a total of $4,169,349.86 for 258,711 shares, this is the most they've acquired in one year. In 2018 Daniel Abdun-Nabi cashed out on 257,660 shares for a total of $10,155,799.86, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
REGENXBIO Inc. (RGNX) Snapshot price: $11.48
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 29
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 25
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 24
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 5
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Emergent BioSolutions Inc. (EBS) Snapshot price: $7.55
CEO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -9.27% | -14.56K |
$58.11 | -$846,328.45 | 142.62K |
Scheduled
|
Mar 4
| ||
Form 4
| -5.63% | -9.38K |
$58.93 | -$553,059.45 | 157.18K |
Feb 26 - Feb 28
| |||
Form 4
|
—
|
0
|
$39.19 | -$1,524,803.18 | 166.57K |
Scheduled
|
Sep 14 - Sep 17
| ||
Form 4
| -15.60% | -30.78K |
$36.78 | -$4,660,430.26 | 166.57K |
Scheduled
|
Sep 4 - Sep 5
| ||
Form 4
| -7.41% | -15.79K |
$52.11 | -$822,614.75 | 197.34K |
Jun 5
| |||
Form 4
| -3.54% | -7.83K |
$51.84 | -$405,648.00 | 213.13K |
Mar 9
| |||
Form 4
| +8.24% | 16.82K |
$49.86 | -$494,755.39 | 220.95K |
Feb 27 - Feb 28
| |||
Form 4
|
—
|
0
|
$31.17 | -$733,193.82 | 204.13K |
Scheduled
|
Jan 2
| ||
Form 4
|
—
|
0
|
$30.22 | -$631,000.00 | 204.13K |
Scheduled
|
Dec 13
| ||
Form 4
|
—
|
0
|
$29.99 | -$805,168.76 | 204.13K |
Scheduled
|
Nov 3
| ||
Form 4
|
—
|
0
|
$30.98 | -$268,320.00 | 204.13K |
Scheduled
|
Sep 27
| ||
Form 4
|
—
|
0
|
$29.62 | -$227,700.00 | 204.13K |
Scheduled
|
Aug 31
| ||
Form 4
| -8.50% | -18.96K |
$31.02 | -$588,256.38 | 204.13K |
Mar 9 - Mar 10
| |||
Form 4
| +17.36% | 32.99K |
$30.63 | -$189,415.92 | 223.1K |
Feb 28
| |||
Form 4
| +0.50% | 943 |
$30.63 | $28,884.09 | 190.1K |
Feb 27
| |||
Form 4
| +10.64% | 18.2K |
$22.90 | -$331,829.31 | 189.16K |
Scheduled
|
Aug 1 - Jan 10
| ||
Form 4
| -4.84% | -8.70K |
$43.74 | -$380,494.26 | 170.97K |
Scheduled
|
Jun 1
| ||
Form 4
| -4.62% | -8.70K |
$42.00 | -$365,442.00 | 179.66K |
Scheduled
|
May 20
| ||
Form 4
| -4.42% | -8.70K |
$40.17 | -$349,559.34 | 188.37K |
Scheduled
|
Apr 18
| ||
Form 4
| -3.19% | -6.49K |
$34.22 | -$222,190.46 | 197.07K |
Mar 11
| |||
Form 4
| -7.82% | -17.28K |
$34.48 | -$595,664.12 | 203.56K |
Mar 9 - Mar 10
| |||
Form 4
| +19.14% | 35.47K |
—
|
—
| 220.84K |
Mar 1
| |||
Form 4
|
—
|
0
|
$28.98 | -$1,273,982.71 | 185.37K |
Scheduled
|
Dec 23 - Dec 24
| ||
Form 4
| +0.82% | 1.5K |
$31.01 | -$33.67 | 185.37K |
Dec 15
| |||
Form 4
| -0.51% | -936.00 |
—
|
—
| 183.87K |
May 14
| |||
Form 4
| +16.69% | 26.43K |
$28.93 | -$600,551.37 | 184.81K |
Mar 10 - Mar 12
| |||
Form 4
| +0.91% | 4.34K |
$22.53 | -$8.79 | 483.32K |
Dec 24
| |||
Form 4
| +0.33% | 506 |
$18.44 | $9,330.64 | 154.04K |
May 31
| |||
Form 4
| -1.42% | -2.25K |
$27.06 | -$60,830.88 | 155.53K |
Mar 14
| |||
Form 4
| -1.88% | -3.02K |
$27.15 | -$82,020.15 | 157.78K |
Mar 12
| |||
Form 4
| +55.28% | 57.25K |
$28.09 | -$122,107.23 | 160.8K |
Mar 11
| |||
Form 4
| +0.73% | 749 |
$19.08 | $14,290.92 | 103.37K |
Nov 30
| |||
Form 4
| +4.80% | 4.61K |
$10.13 | $46,729.69 | 100.62K |
Nov 7
| |||
Form 4
| +0.84% | 800 |
$12.07 | $9,656.00 | 96.01K |
May 31
| |||
Form 4
| -2.31% | -2.25K |
$14.46 | -$32,506.08 | 95.21K |
Mar 14
| |||
Form 4
| +56.86% | 35.33K |
$14.90 | -$82,025.55 | 97.46K |
Mar 8 - Mar 12
| |||
Form 4
| +4.41% | 2.62K |
$12.97 | $5.63 | 62.15K |
Dec 27
| |||
Form 4
| +77.90% | 26.07K |
$16.05 | -$35,069.25 | 59.52K |
Mar 13 - Mar 14
| |||
Form 4
| -6.44% | -2.30K |
$14.49 | -$33,370.47 | 33.46K |
Mar 8
| |||
Form 4
| -12.41% | -5.07K |
$16.77 | -$2,832,765.43 | 35.76K |
May 31 - Jun 1
| |||
Form 4
| +105.90% | 21K |
—
|
—
| 40.83K |
Mar 15
| |||
Form 4
| -10.45% | -2.31K |
$21.15 | -$48,962.25 | 19.83K |
Mar 8
| |||
Form 4
| -42.91% | -18.15K |
$18.77 | -$340,644.00 | 24.14K |
Scheduled
|
Jul 28 - Jul 29
| ||
Form 4
| +109.90% | 22.14K |
—
|
—
| 42.3K |
Mar 9
| |||
Form 4
| -9.03% | -2.00K |
$16.27 | -$32,543.00 | 20.15K |
Aug 18
| |||
Form 4
| -17.90% | -11.00K |
$17.21 | -$189,475.00 | 50.45K |
Aug 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 10
| |||
Form 4
| -18.85% | -7.70K |
$20.01 | -$154,105.36 | 33.15K |
Nov 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 11
| |||
Form 4
| +5.73% | 2.21K |
$6.28 | -$34,487.30 | 40.85K |
Scheduled
|
Jun 28 - Jun 29
| ||
Form 4
| +1.83% | 2.1K |
$6.11 | -$33,639.42 | 116.9K |
Scheduled
|
Jun 26 - Jun 27
| ||
Form 4
| +3.66% | 2.53K |
$5.89 | -$27,254.08 | 71.52K |
Scheduled
|
Jun 22 - Jun 25
| ||
Form 4
| +9.64% | 2.99K |
$5.97 | -$23,798.34 | 34.01K |
Scheduled
|
Jun 20 - Jun 21
| ||
Form 4
| +9.07% | 2.58K |
$6.35 | -$31,648.50 | 31.02K |
Scheduled
|
Jun 18 - Jun 19
| ||
Form 4
| +9.71% | 2.52K |
$5.86 | -$26,916.00 | 28.44K |
Scheduled
|
Jun 14 - Jun 15
| ||
Form 4
| +25.26% | 5.23K |
$5.66 | -$37,436.78 | 25.92K |
Scheduled
|
Jun 12 - Jun 13
| ||
Form 4
| +19.38% | 3.36K |
$5.68 | -$24,175.35 | 20.7K |
Scheduled
|
Jun 8 - Jun 11
| ||
Form 4
| +43.91% | 5.29K |
$5.84 | -$21,877.84 | 17.34K |
Scheduled
|
Jun 6 - Jun 7
| ||
Form 4
| +50.42% | 4.04K |
$6.18 | -$17,941.02 | 12.05K |
Scheduled
|
Jun 4 - Jun 5
| ||
Form 4
| +110.18% | 4.2K |
$6.42 | -$19,550.29 | 8.01K |
Scheduled
|
May 31 - Jun 1
| ||
Form 4
|
∞
| 3.81K |
$6.59 | -$20,052.60 | 3.81K |
Scheduled
|
May 29 - May 30
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 20
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Aptevo Therapeutics Inc. (APVO) Snapshot price: $0.325
Board Directors
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 17
| |||
Form 4
| +46.56% | 88 |
—
|
—
| 277 |
Jun 1 - Jun 2
| |||
Form 4
| +74.90% | 3.57K |
—
|
—
| 8.34K |
Aug 9
| |||
Form 4
| +6.64% | 297 |
—
|
—
| 4.77K |
Jun 1 - Jun 2
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 9
| |||
Form 4
| +3.82% | 298 |
—
|
—
| 8.11K |
Jun 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 27
| |||
Form 4
| +17.98% | 16.67K |
$0.90 | $15,000.30 | 109.35K |
Jun 25
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 3
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |